Contacts
Every person and organization shaping the peptide landscape — researchers publishing the science, clinicians applying it, influencers amplifying it, and pharma companies bringing it to market.
Podcasters, biohackers, and content creators shaping the peptide conversation
Scientists and academics publishing the foundational peptide science
Physicians and practitioners working with peptide therapy
Companies developing and manufacturing FDA-approved peptide-based drugs
20 results
Eli Lilly was an American businessman who founded Eli Lilly and Company, a pharmaceutical company known for developing medications including tirzepatide and dulaglutide.
Novo Nordisk is a Danish pharmaceutical company focused on diabetes and obesity treatments, known for products like semaglutide and liraglutide.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois, known for producing drugs to treat a variety of medical conditions and conducting extensive clinical research.
Amgen Inc. is a leading American biopharmaceutical company headquartered in Thousand Oaks, California, specializing in the development and commercialization of innovative therapies for severe diseases such as osteoporosis, hyperlipidemia, and autoimmune disorders.
AstraZeneca is a multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK. It focuses on developing treatments for major diseases such as oncology, cardiovascular conditions, and diabetes.
Bachem is a Swiss company known for peptide manufacturing and the production of GLP-1 APIs.
UK-based biopharma developing Bicycle drug conjugates (BDCs) — fully synthetic constrained bicyclic peptides for cancer. Lead candidate zeladenoson targets Nectin-4 in solid tumors. NASDAQ: BCYC.
Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specializing in reproductive health, maternal health, gastroenterology, and urology. It has been developing treatments for mothers and babies for over five decades.
Genentech is an American biotechnology company based in South San Francisco, California, operating as a subsidiary of Roche. It focuses on developing and manufacturing innovative pharmaceutical products.
Ipsen is a French biopharmaceutical company founded in 1929, focusing on drug development and commercialization in oncology, rare diseases, and neuroscience. The company operates globally with presence in over 30 countries.
Lonza Group AG is a Swiss multinational company providing custom manufacturing services for biopharmaceuticals and offering product development support in the pharmaceutical, biotechnology, and nutrition sectors.
Merck & Co., Inc. is a leading pharmaceutical company known for its cancer treatments and vaccines, notably Keytruda (pembrolizumab) and Gardasil.
Pfizer Inc. is a leading pharmaceutical company founded in 1849, specializing in the development and production of medications and vaccines for various medical conditions.
Polypeptide Group is a pharmaceutical company focusing on peptide contract manufacturing and research, notably involving semaglutide API and various clinical studies related to peptides and incretin hormones.
Protagonist Therapeutics is a pharmaceutical company developing rusfertide for polycythemia vera, with regulatory designations and an FDA New Drug Application submission.
Clinical-stage biopharma focused on complement system disorders. Developed zilucoplan (Zilbrysq), a macrocyclic peptide C5 inhibitor for myasthenia gravis. Acquired by UCB in 2020.
Radius Health is a pharmaceutical company known for developing and selling abaloparatide, a medication used to treat osteoporosis. The company also conducts research on bone health and metabolism.
Sun Pharmaceutical Industries Limited is a leading Indian multinational pharmaceutical company with global operations, specializing in the manufacture and sale of pharmaceutical formulations and APIs across over 100 countries.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company specializing in generic drugs and branded medications such as Austedo for Huntington's chorea and tardive dyskinesia, and Ajovy (fremanezumab) for migraine prevention.
Zealand Pharma A/S is a Danish biotechnology company based in Søborg, Copenhagen, focusing on the development of peptide-based medicines for metabolic diseases such as diabetes and obesity. The company has a subsidiary in the US and participates in clinical trials for various cancers and autoimmune conditions.